/

Companies / Crosslink Therapeutics

Crosslink Therapeutics

United States

Crosslink Therapeutics is developing biologics for the treatment of cancer

Crosslink Therapeutics, based in United States, has 1 investor on file, among them Cure Ventures. Its latest round on record is Series A, 20 Oct 2026. Its site was last checked 6 Nov 2026: site answers.

Funding

1 round on record
Latest roundSeries A20 Oct 2026
Since that round1 monthno later round on record
Oct 2026Series AInvestors not named

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

1 investor on file
InvestorEvidenceType
Cure VenturesPortfolio pageVenture capital

More from Cure Ventures

10 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

See Cure Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Crosslink Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Cure Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/xlinktx.com/investors

# also
GET /v1/companies/xlinktx.com
GET /v1/companies/xlinktx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing